StockData
EoCene Ltd. logo

EoCene Ltd. (EOCN) stock

EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.46−0.07 (-2.77%)

Close on Nov 17, 2026Market cap $2.46MP/E –Yield –

EoCene cash

Cash and short-term investments held at the end of each period.

EoCene's cash was $8.77M at Jun 30, 2026. For fiscal 2025 it was $11.01M, down 7.0% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $47.08M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.01M-7.0%
FY2024Dec 31, 2024$11.84M+13.9%
FY2023Dec 31, 2023$10.39M-24.6%
FY2022Dec 31, 2022$13.79M-60.4%
FY2021Dec 31, 2021$34.82M-26.0%
FY2020Dec 31, 2020$47.08M+7.3%
FY2019Dec 31, 2019$43.87M+45.1%
FY2018Dec 31, 2018$30.23M+132.1%
FY2017Dec 31, 2017$13.02M+320.4%
FY2016Dec 31, 2016$3.10M-25.5%
FY2015Dec 31, 2015$4.16M-86.0%
FY2014Dec 31, 2014$29.74M+21605.1%
FY2013Dec 31, 2013$137.00K-80.9%
FY2012Dec 31, 2012$718.00K+391.8%
FY2011Dec 31, 2011$146.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.77M-25.9%
Q4 FY2025Dec 31, 2025$11.01M+41.6%
Q3 FY2025Sep 30, 2025$11.49M+10.6%
Q2 FY2025Jun 30, 2025$13.06M+51.7%
Q4 FY2024Dec 31, 2024$11.84M-14.1%
Q2 FY2024Jun 30, 2024$7.78M-65.3%
Q4 FY2023Dec 31, 2023$10.39M-70.2%
Q2 FY2023Jun 30, 2023$8.61M-82.5%
Q4 FY2022Dec 31, 2022$13.79M-70.7%
Q2 FY2022Jun 30, 2022$22.38M-32.1%
Q4 FY2021Dec 31, 2021$34.82M-20.6%
Q2 FY2021Jun 30, 2021$49.26M+20.0%
Q4 FY2020Dec 31, 2020$47.08M+55.8%
Q2 FY2020Jun 30, 2020$32.96M+435.8%
Q4 FY2019Dec 31, 2019$43.87M+236.9%
Q2 FY2019Jun 30, 2019$41.06M+2250.3%
Q4 FY2018Dec 31, 2018$30.23M+876.0%
Q2 FY2018Jun 30, 2018$6.15M+108.8%
Q4 FY2017Dec 31, 2017$13.02M+213.3%
Q2 FY2017Jun 30, 2017$1.75M-76.1%
Q4 FY2016Dec 31, 2016$3.10M-89.6%
Q2 FY2016Jun 30, 2016$2.95M+2050.4%
Q4 FY2015Dec 31, 2015$4.16M+478.8%
Q2 FY2015Jun 30, 2015$7.32M+4916.4%
Q4 FY2014Dec 31, 2014$29.74M–
Q4 FY2013Dec 31, 2013$137.00K–
Q4 FY2012Dec 31, 2012$718.00K–
Q4 FY2011Dec 31, 2011$146.00K–

More EoCene figures

See a number that looks wrong?